glp-1 obesity drug news today september 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo World Health Organization recommends GLP-1
Description
SUMMARY: GLP-1 receptor agonists are an increasingly popular class of medications for weight loss and diabetes management
February 16, 2024
DOI: 10.3390/ijms241310449
Protective effects and mechanisms of polyethylene glycol loxenatide against hyperglycemia and liver injury in db/db diabetic mice
Tara Narula breaks down new research suggesting GLP-1 medications may be linked to a lower risk of breast cancer diagnoses
P.WuQ.DuY.GurbuzS.et al (2023)
